MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy
Open Access
- 14 July 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (14), 7526
- https://doi.org/10.3390/ijms22147526
Abstract
In the last decades, a kind of small non-coding RNA molecules, called as microRNAs, has been applied as negative regulators in various types of cancer treatment through down-regulation of their targets. More recent studies exert that microRNAs play a critical role in the EMT process of cancer, promoting or inhibiting EMT progression. Interestingly, accumulating evidence suggests that pure compounds from natural plants could modulate deregulated microRNAs to inhibit EMT, resulting in the inhibition of cancer development. This small essay is on the purpose of demonstrating the significance and function of microRNAs in the EMT process as oncogenes and tumor suppressor genes according to studies mainly conducted in the last four years, providing evidence of efficient target therapy. The review also summarizes the drug candidates with the ability to restrain EMT in cancer through microRNA regulation.Funding Information
- National Natural Science Foundation of China (82003879, 82004056)
- Youth Talent Promotion Projectof China Association for Science and Technology (CACM-2020-QNRC1-01)
This publication has 142 references indexed in Scilit:
- Ovol Proteins: Guardians against EMT during Epithelial DifferentiationDevelopmental Cell, 2014
- The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and TreatmentJournal of Clinical Medicine, 2013
- MicroRNA regulation of epithelial plasticity in cancerCancer Letters, 2013
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cellsCancer Letters, 2013
- MicroRNA Control of Invasion and Metastasis PathwaysFrontiers in Genetics, 2011
- MicroRNA involvement in the pathogenesis and management of breast cancerJournal of Clinical Pathology, 2009
- Role of the epithelial-mesenchymal transition regulator Slug in primary human cancersFrontiers in Bioscience-Landmark, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- MicroRNA genes are transcribed by RNA polymerase IIThe EMBO Journal, 2004
- The nuclear RNase III Drosha initiates microRNA processingNature, 2003